News

Verana Health has entered into a research collaboration with Janssen Research & Development, a unit of Johnson & Johnson, that focuses on curating real-world data…

Innovations for treating presbyopia are moving on two parallel tracks: accommodative intraocular lenses (IOLs) that are both reversable and exchangeable, and pharmaceutical drops to temporarily…

Heru, an ophthalmology development company creating an artificial intelligence-driven vision diagnostics and augmentation platform, has just emerged from “stealth mode” and made its public debut…

With the acquisition of Vienna-based biotech Panoptes Pharma, Eye Gate Pharmaceuticals has expanded its pipeline of nonsteroidal products targeting ocular inflammation by adding Panoptes’ PP-001,…

Clinical trials on many levels have been disrupted over the past year, and the current surge can cause further disruption as different regions and cities…

Robert Kissling, VP, medical affairs for Bausch + Lomb, says forced changes can be the mother of innovation. If so, then 2020 should have sired…

Novartis is doubling down on its mission to end preventable blindness, which has translated into a host of moves to strengthen its commitment to age-related…

The coronavirus pandemic became the 800-pound gorilla dragging down the economy this year, but 2020 turned out to be a stellar one for investors in…

By acquiring the rights to Hemera Biosciences’ gene therapy candidate to treat geographic atrophy – the debilitating end-stage form of dry age-related macular degeneration –…